Dynamic circulating tumor DNA quantificaton for the individualization of non-small-cell lung cancer patients treatment

BACKGROUND: Liquid biopsy has evolved from being a promising line to becoming a validated approach for biomarker testing. However, its utility for individualization of therapy has been scarcely reported. In this study, we show how monitoring levels of EGFR mutation in plasma can be useful for the in...

Descripción completa

Detalles Bibliográficos
Autores principales: Provencio, Mariano, Torrente, María, Calvo, Virgina, Gutiérrez, Lourdes, Pérez-Callejo, David, Pérez-Barrios, Clara, Barquín, Miguel, Royuela, Ana, Rodriguez-Alfonso, Begoña, Sotelo, Miguel, Cruz-Bermúdez, Juan Luis, Mendez, Miriam, Cruz-Bermúdez, Alberto, Romero, Atocha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601139/
https://www.ncbi.nlm.nih.gov/pubmed/28947971
http://dx.doi.org/10.18632/oncotarget.20016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601139/
https://www.ncbi.nlm.nih.gov/pubmed/28947971
http://dx.doi.org/10.18632/oncotarget.20016

Ejemplares similares